Zooming out: Hims ad references its suite of weight loss treatments but highlights its compounded semaglutide offering, a lower-cost copycat GLP-1 that has become exceedingly popular with patients whose health plans dont cover the branded equivalents
The front-facing outcome
Last week, Sun Pharma announced plans to introduce its generic semaglutide injection in the country, and now Novo Nordisk is set to launch Extensior, a lower-cost authorized copy of Ozempic (semaglutide), in South Africa on July 27, through a partnership with healthcare company Acino, in the same 0.25 mg, 0.5 mg, and 1 mg doses as Ozempic, and will be priced below the branded product
Drink enough water and watch for dark urine, dizziness, or dry mouth
Providers track progress, adjusting doses to maintain steady weight loss